Nyumbani › Leukemia ya Limfosaiti ya Muda Mrefu › Oregon › Eugene
Majaribio ya kliniki ya Leukemia ya Limfosaiti ya Muda Mrefu katika Eugene, OR
Masomo 6 ya Leukemia ya Limfosaiti ya Muda Mrefu yanatafuta washiriki katika vituo vya Eugene na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.
Maandishi rasmi ya utafiti (Kiingereza)
Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
InaajiriHatua 3
- Oncology Associates of Oregon Willamette Valley Cancer Center, Eugene
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
InaajiriHatua 3
- Oncology Associates of Oregon Willamette Valley Cancer Center, Eugene
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
InaajiriHatua 3
- Oncology Associates of Oregon Willamette Valley Cancer Center, Eugene
Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies
InaajiriHatua 1/2
- Oncology Associates of Oregon, Eugene
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
InaajiriHatua 2
- Williamette Valley Cancer Institute & Research Center, Eugene
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
InaajiriHatua 3
- Willamette Valley Cancer Institute and Research Center /ID# 266326, Eugene
Majaribio ya Leukemia ya Limfosaiti ya Muda Mrefu katika miji mingine
- Boston, MAUtafiti 31
- Columbus, OHUtafiti 28
- Durham, NCUtafiti 27
- Washington, DCUtafiti 22
- Seattle, WAUtafiti 20
- Rochester, MNUtafiti 19
- New York City, NYUtafiti 18
- Houston, TXUtafiti 17
- Baldwin Park, CAUtafiti 16
- Milwaukee, WIUtafiti 15
- Chicago, ILUtafiti 14
- Cincinnati, OHUtafiti 14
Masomo mengine katika Eugene
- Saratani ya Mapafu Isiyo na Selu NdogoUtafiti 13
- Kansari ya MayaiUtafiti 9
- Saratani ya EndometrialUtafiti 8
- Saratani ya MatitiUtafiti 7
- Multiple MyelomaUtafiti 6
- Saratani ya MetastasiUtafiti 6
- Saratani (aina zote)Utafiti 6
- Matumizi ya Dawa na UtegemeziUtafiti 5
- Saratan ya MapafuUtafiti 5
- Uharibifu wa MakulaUtafiti 5
- UnenepuUtafiti 4
- Saratani ya ProstateUtafiti 3
Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.